Search This Blog

Tuesday, April 14, 2026

Operation Epic Fury takes aim at banks handling Iranian money

 The Trump administration is sending letters to banks in four areas about handling Iranian money.

The letter obtained by FOX Business says the Treasury Department has evidence that banks in Oman, the UAE, Hong Kong and China have allowed Iranian funds used for illicit activities to be funneled through them.

A senior administration official not authorized to speak publicly says this is the first step to adding secondary sanctions on those banks, which would cut them off from the U.S. financial system.

"Now is the time to finally disable Iran’s ability to support terrorism, threaten the region and global markets, and seek to continue its nuclear and ballistic missile program, which the U.N. has prohibited," the letter said.

Treasury Secretary Scott Bessent on Tuesday warned companies and countries against paying Iran to transit the Strait of Hormuz because that opens them up to secondary sanctions. Bessent is leading the sanction charge in Operation Epic Fury.

This letter is different, but shows the administration's willingness to up the ante and truly go after the Iranian money.

The U.S. waiver to sell Iranian oil at sea will expire on April 19.

https://www.foxbusiness.com/politics/trump-admins-operation-epic-fury-takes-aim-banks-handling-iranian-money

Pending $1.6B merger speculation ignites low-float breakout and volatility halts in AFJK

 


AFJK, a SPAC, has been working toward a business combination with United Hydrogen Group (a hydrogen/energy business) valued around $1.5–1.6 billion that would result in a Nasdaq-listed entity. The company recently announced its 17th one-month extension of the deadline (to May 6, 2026) via a small trust account deposit and promissory note on April 7, with no brand-new press release or filing appearing on April 14. The stock exhibited extreme volatility in early April (e.g., massive volume spike and +140% move on April 9 to a high near $85, followed by pullbacks). On April 14, it broke out sharply from the prior close of ~$40.40, surging over 60–72% intraday to the $66 area on elevated relative volume. With a very low float (~2.8 million shares), the move triggered multiple LULD volatility halts. Trader chatter on X highlighted the “$1.6B Nasdaq listing catalyst,” momentum above resistance (~$50), and speculative buying in this low-float name. The price action reflects classic retail/momentum-driven trading on the long-pending deal rather than a discrete new fundamental trigger.

https://finviz.com/quote.ashx?t=AFJK&p=d

Piper Sandler upgrades Biogen to Overweight, raises target to $214 on Apellis acquisition

 

Piper Sandler upgrades Biogen to Overweight, raises target to $214 on Apellis acquisition

  • Piper Sandler says Apellis acquisition should help offset declines in Biogen's legacy multiple sclerosis franchise.

Avanos Medical announces definitive agreement to be acquired by American Industrial Partners

 Avanos Medical announces definitive agreement to be acquired by American Industrial Partners for $25.00 per share in $1.272 billion cash deal

https://finviz.com/quote.ashx?t=AVNS&p=d

https://www.zerohedge.com/political/dei-practices-reduce-productivity-cost-94-billion-annually-white-house-economic-report

https://www.zerohedge.com/geopolitical/iran-mulls-hormuz-shipping-pause-preserve-talks-avoid-trump-blockade-showdown-us

https://breakingthenews.net/Article/Russia:-Iran-war-may-resume-with-'greater-intensity'/66068038